Cognitive disorders and dementia in CKD: The neglected kidney-brain axis

Journal of the American Society of Nephrology

Volumn 24, Issue 3, 2013, Pages 353-363

  Bugnicourt, Jean Marc ^a,b,c   Godefroy, Olivier ^a,b   Chillon, Jean Marc ^c,d   Choukroun, Gabriel ^a,c   Massy, Ziad A ^a,c,d  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b Amiens University Medical Center and Jules Verne University of Picardy   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DAMAGE; BRAIN FUNCTION; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; DEMENTIA; HUMAN; KIDNEY DISEASE; NERVE DEGENERATION; NEUROIMAGING; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASCULAR DISEASE;

EID: 84874591688     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012050536     Document Type: Review

References (86)

1. Couchoud C, Lassalle M, Stengel B, Jacquelinet C: [Renal Epidemiology and Information Network: 2006 annual report]. Nephrol Ther 4[Suppl 2]: S53-S167, 2008
2. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW,McBeanM,Murray A, St PeterW, Guo H, Gustafson S, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, SkeansM, Snyder J, SolidC,Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L: US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 57[Suppl 1]: A8, e1-e526, 2011
3. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R,Gilbertson D,GrimmR, Liu J, Louis T, Manning W, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li Q, Li S, Qiu Y, Roberts T, SkeansM, Snyder J, SolidC,Wang C, Weinhandl E, Zhang R, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Berrini D, Constantini E, Everson S, Eggers P, Agodoa L: Excerpts from the United States Renal Data System 2006 annual data report. AmJ Kidney Dis 49: A6-7, S1-296, 2007. (Pubitemid 44959235)
4. Kurella M, Luan J, Yaffe K, Chertow GM: Validation of the Kidney Disease Quality of Life (KDQOL) cognitive function subscale. Kidney Int 66: 2361-2367, 2004 (Pubitemid 41115301)
5. Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA: Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant 24: 2446-2452, 2009
6. Kurella M, Chertow GM, Luan J, Yaffe K: Cognitive impairment in chronic kidney disease. J Am Geriatr Soc 52: 1863-1869, 2004 (Pubitemid 41710270)
7. Madan P, Kalra OP, Agarwal S, Tandon OP: Cognitive impairment in chronic kidney disease. Nephrol Dial Transplant 22: 440-444, 2007 (Pubitemid 46189887)
8. Antoine V, Souid M, André C, Barthélémy F, Saint-Jean O: [Symptoms and quality of life of hemodialysis patients aged 75 and over]. Nephrologie 25: 89-96, 2004 (Pubitemid 38660757)
9. Fazekas G, Fazekas F, Schmidt R, Kapeller P, Offenbacher H, Krejs GJ: Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci 134: 83-88, 1995
10. Sehgal AR,Grey SF,DeOreo PB,Whitehouse PJ: Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis 30: 41-49, 1997 (Pubitemid 27284373)
11. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, McDowell I: Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349: 1793-1796, 1997 (Pubitemid 27257555)
12. Folstein MF, Folstein SE, McHugh PR: "Minimental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198, 1975
13. Godefroy O, Fickl A, Roussel M, Auribault C, Bugnicourt JM, Lamy C, Canaple S, Petitnicolas G: Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke 42: 1712-1716, 2011
14. Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, Smith GE, Hochhalter AK, Collins AJ, Kane RL: Cognitive impairment in hemodialysis patients is common. Neurology 67: 216-223, 2006 (Pubitemid 44305402)
15. Kurella M, Mapes DL, Port FK, Chertow GM Correlates and outcomes of dementia among dialysis patients: The Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 21: 2543-2548, 2006 (Pubitemid 44644529)
16. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D'Agostino RB, White LR: Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 42: 115-119, 1992
17. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO: Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 262: 2551-2556, 1989
18. Murray AM, Pederson SL, Tupper DE, Hochhalter AK, Miller WA, Li Q, Zaun D, Collins AJ, Kane R, Foley RN: Acute variation in cognitive function in hemodialysis patients: A cohort study with repeated measures. Am J Kidney Dis 50: 270-278, 2007 (Pubitemid 47095078)
19. Buoncristiani U, Alberti A, Gubbiotti G, Mazzotta G, Gallai V, Quintaliani G, Gaburri M: Better preservation of cognitive faculty in continuous ambulatory peritoneal dialysis. Perit Dial Int 13[Suppl 2]: S202-S205, 1993 (Pubitemid 23261179)
20. Tilki HE, Akpolat T, Tunali G, Kara A, Onar MK: Effects of haemodialysis and continuous ambulatory peritoneal dialysis on P300 cognitive potentials in uraemic patients. Ups J Med Sci 109: 43-48, 2004 (Pubitemid 39330060)
21. Radic J, Ljutic D, Radic M, Kovacic V, Dodig-Curkovic K, Šain M: Kidney transplantation improves cognitive and psychomotor functions in adult hemodialysis patients. Am J Nephrol 34: 399-406, 2011
22. Hailpern SM, Melamed ML, Cohen HW, Hostetter TH: Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 18: 2205-2213, 2007 (Pubitemid 47044805)
23. KurellaM, ChertowGM, Fried LF, Cummings SR, Harris T, Simonsick E, Satterfield S, Ayonayon H, Yaffe K: Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study. J Am Soc Nephrol 16: 2127-2133, 2005 (Pubitemid 41716444)
24. Yaffe K, Ackerson L, Kurella Tamura M, Le Blanc P, Kusek JW, Sehgal AR, Cohen D, Anderson C, Appel L, Desalvo K, Ojo A, Seliger S, Robinson N, Makos G, Go AS; Chronic Renal Insufficiency Cohort Investigators: Chronic kidney disease and cognitive function in older adults: Findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc 58: 338-345, 2010
25. Buchman AS, Tanne D, Boyle PA, Shah RC, Leurgans SE, Bennett DA: Kidney function is associated with the rate of cognitive decline in the elderly. Neurology 73: 920-927, 2009
26. Etgen T, Sander D, Chonchol M, Briesenick C, Poppert H, Förstl H, Bickel H: Chronic kidney disease is associated with incident cognitive impairment in the elderly: The INVADE study. Nephrol Dial Transplant 24: 3144-3150, 2009
27. Kurella Tamura M, Wadley V, Yaffe K, McClure LA, Howard G, Go R, Allman RM, Warnock DG, McClellan W: Kidney function and cognitive impairment in US adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis 52: 227-234, 2008 (Pubitemid 351978145)
28. Seliger SL, Siscovick DS, Stehman-BreenCO, Gillen DL, Fitzpatrick A, Bleyer A, Kuller LH: Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition Study. J Am Soc Nephrol 15: 1904-1911, 2004 (Pubitemid 38822071)
29. Helmer C, Stengel B, MetzgerM, Froissart M, Massy ZA, Tzourio C, Berr C, Dartigues JF: Chronic kidney disease, cognitive decline, and incident dementia: The 3C Study. Neurology 77: 2043-2051, 2011
30. Slinin Y, PaudelML, Ishani A, Taylor BC, Yaffe K, Murray AM, Fink HA, Orwoll ES, Cummings SR, Barrett-Connor E, Jassal S, Ensrud KE; Osteoporotic Fractures in Men Study Group: Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc 56: 2082-2088, 2008
31. Murray AM: Cognitive impairment in the aging dialysis and chronic kidney disease populations: An occult burden. Adv Chronic Kidney Dis 15: 123-132, 2008 (Pubitemid 351343871)
32. Passer JA: Cerebral atrophy in end-stage uremia. Proc Clin Dial Transplant Forum 7: 91-94, 1977
33. Kamata T, Hishida A, Takita T, Sawada K, Ikegaya N,Maruyama Y,Miyajima H, Kaneko E: Morphologic abnormalities in the brain of chronically hemodialyzed patients without cerebrovascular disease. Am J Nephrol 20: 27-31, 2000 (Pubitemid 30047866)
34. Savazzi GM, Cusmano F, Musini S: Cerebral imaging changes in patients with chronic renal failure treated conservatively or in hemodialysis. Nephron 89: 31-36, 2001 (Pubitemid 32799830)
35. Cusmano F, Savazzi GM: Cerebral computed tomography in uremic and hemodialyzed patients. J Comput Assist Tomogr 10: 567-570, 1986 (Pubitemid 16057304)
36. Bugnicourt JM, Chillon JM, Massy ZA, Canaple S, Lamy C, Deramond H, Godefroy O: High prevalence of intracranial artery calcification in stroke patients with CKD: A retrospective study. Clin J Am Soc Nephrol 4: 284-290, 2009
37. Chillon JM, Mozar A, Six I, Maizel J, Bugnicourt JM, Kamel S, SlamaM, Brazier M, Massy ZA: Pathophysiological mechanisms and consequences of cardiovascular calcifications: Role of uremic toxicity. Ann Pharm Fr 67: 234-240, 2009
38. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl JMed 348: 1215-1222, 2003 (Pubitemid 36359297)
39. Vermeer SE, LongstrethWT Jr., Koudstaal PJ: Silent brain infarcts: A systematic review. Lancet Neurol 6: 611-619, 2007 (Pubitemid 46921055)
40. Kobayashi M, Hirawa N, Morita S, Yatsu K, Kobayashi Y, Yamamoto Y, Saka S, Toya Y, Yasuda G, Umemura S: Silent brain infarction and rapid decline of kidney function in patients with CKD: A prospective cohort study. AmJ Kidney Dis 56: 468-476, 2010
41. Kim CD, Lee HJ, Kim DJ, Kim BS, Shin SK, Do JY, Jang MH, Park SH, Kim YS, Kim YL: High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis 50: 98-107, 2007
42. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ: Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52: 168-174, 2002 (Pubitemid 34810596)
43. Pantoni L: Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9: 689-701, 2010
44. Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MM: Kidney function is related to cerebral small vessel disease. Stroke 39: 55-61, 2008
45. Khatri M, Wright CB, Nickolas TL, Yoshita M, Paik MC, Kranwinkel G, Sacco RL, DeCarli C: Chronic kidney disease is associated with white matter hyperintensity volume: The NorthernManhattan Study (NOMAS). Stroke 38: 3121-3126, 2007 (Pubitemid 350175724)
46. Wada M, Nagasawa H, Kurita K, Koyama S, Arawaka S, Kawanami T, Tajima K, Daimon M, Kato T: Cerebral small vessel disease and C-reactive protein: Results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 264: 43-49, 2008 (Pubitemid 350184068)
47. Martinez-Vea A, Salvadó E, Bardají A, Gutierrez C, Ramos A, García C, Compte T, Peralta C, Broch M, Pastor R, Angelet P, Marcas L, Saurí A, Oliver JA: Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis 47: 241-250, 2006 (Pubitemid 43121327)
48. Debette S, Beiser A, DeCarli C, Au R, Himali JJ, Kelly-HayesM, Romero JR, Kase CS,Wolf PA, SeshadriS: Association ofMRImarkers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: The Framingham Offspring Study. Stroke 41: 600-606, 2010
49. Yokoyama S, Hirano H, Uomizu K, Kajiya Y, Tajitsu K, Kusumoto K: High incidence of microbleeds in hemodialysis patientsdetected by T2-weighted gradient-echo magnetic resonance imaging. Neurol Med Chir (Tokyo) 45: 556-560, discussion 560, 2005 (Pubitemid 41729066)
50. Shima H, Ishimura E, Naganuma T, Yamazaki T, Kobayashi I, Shidara K, Mori K, Takemoto Y, Shoji T, Inaba M, Okamura M, Nakatani T, Nishizawa Y: Cerebral microbleeds in predialysis patients with chronic kidney disease. Nephrol Dial Transplant 25: 1554-1559, 2010
51. Cho AH, Lee SB, Han SJ, Shon YM, YangDW, Kim BS: Impaired kidney function and cerebral microbleeds in patients with acute ischemic stroke. Neurology 73: 1645-1648, 2009
52. Ovbiagele B, Liebeskind DS, Pineda S, Saver JL: Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack. Arch Neurol 67: 45-50, 2010
53. Watanabe A: Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis. J Stroke Cerebrovasc Dis 16: 30-33, 2007 (Pubitemid 46073789)
54. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B: Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 341: c4249, 2010
55. Mogi M, Horiuchi M: Clinical interaction between brain and kidney in small vessel disease. Cardiol Res Pract 2011: 306189, 2011
56. Silvestrini M, Pasqualetti P, Baruffaldi R, Bartolini M, Handouk Y, Matteis M, Moffa F, Provinciali L, Vernieri F: Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 37: 1010-1015, 2006
57. Stefani A, Sancesario G, PierantozziM, Leone G, Galati S, Hainsworth AH, Diomedi M: CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia. J Neurol Sci 283: 109-115, 2009
58. Vicenzini E, RicciardiMC, AltieriM, Puccinelli F, Bonaffini N, Di Piero V, Lenzi GL: Cerebrovascular reactivity in degenerative and vascular dementia: A transcranial Doppler study. Eur Neurol 58: 84-89, 2007 (Pubitemid 47237651)
59. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST: Vascular cognitive impairment. Lancet Neurol 2: 89-98, 2003 (Pubitemid 37443329)
60. Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C, Jagust WJ, Chui HC: Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain 130: 731-739, 2007 (Pubitemid 46410743)
61. Madero M, Gul A, Sarnak MJ: Cognitive function in chronic kidney disease. Semin Dial 21: 29-37, 2008
62. Romero JR, Beiser A, Seshadri S, Benjamin EJ, Polak JF, Vasan RS, Au R, DeCarli C,Wolf PA: Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: The Framingham study. Stroke 40: 1590-1596, 2009
63. Vidal JS, Sigurdsson S, Jonsdottir MK, Eiriksdottir G, Thorgeirsson G, Kjartansson O, Garcia ME, van Buchem MA, Harris TB, Gudnason V, Launer LJ: Coronary artery calcium, brain function and structure: The AGESReykjavik Study. Stroke 41: 891-897, 2010
64. Massy ZA: Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients.NephrolDial Transplant 15
65. Seshadri S, Wolf PA, Beiser AS, Selhub J, Au R, Jacques PF, Yoshita M, Rosenberg IH, D'Agostino RB, DeCarli C: Association of plasma total homocysteine levels with subclinical brain injury: Cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol 65: 642-649, 2008 (Pubitemid 351679660)
66. Fassbender K, Mielke O, Bertsch T, Nafe B, Fröschen S, Hennerici M: Homocysteine in cerebral macroangiography and microangiopathy. Lancet 353: 1586-1587, 1999 (Pubitemid 29219212)
67. Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, Bamford JM, Markus HS: Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 127: 212-219, 2004 (Pubitemid 38055360)
68. Wright CB, Paik MC, Brown TR, Stabler SP, Allen RH, Sacco RL, DeCarli C: Total homocysteine is associated with white matter hyperintensity volume: The Northern Manhattan Study. Stroke 36: 1207-1211, 2005 (Pubitemid 40798740)
69. Lipton SA, Kim WK, Choi YB, Kumar S, D'EmiliaDM, Rayudu PV, Arnelle DR, Stamler JS: Neurotoxicity associated with dual actions of homocysteine at the N-methyl-Daspartate receptor. Proc Natl Acad Sci U S A 94: 5923-5928, 1997
70. Seshadri S: Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? J Alzheimers Dis 9: 393-398, 2006 (Pubitemid 44253353)
71. Kwok T, Lee J, Law CB, Pan PC, Yung CY, Choi KC, Lam LC: A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people. Clin Nutr 30: 297-302, 2011
72. Duron E, Hanon O: Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 4: 363-381, 2008 (Pubitemid 351711965)
73. Duron E, Hanon O: Antihypertensive treatments, cognitive decline, and dementia. J Alzheimers Dis 20: 903-914, 2010
74. in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM: Antihypertensive drugs and incidence of dementia: The Rotterdam Study. Neurobiol Aging 22: 407-412, 2001 (Pubitemid 32510912)
75. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, Kobalava Z, Sarti C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Birkenhäger WH; Systolic Hypertension in Europe Investigators: The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 162: 2046-2052, 2002 (Pubitemid 35168212)
76. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352: 1347-1351, 1998 (Pubitemid 28510916)
77. Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N: Prevention of dementia by antihypertensive drugs: How AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Expert Rev Neurother 9: 1413-1431, 2009
78. Stinghen AE, Pecoits-Filho R: Vascular damage in kidney disease: Beyond hypertension. Int J Hypertens 2011: 232683, 2011
79. Seifter JL, Samuels MA: Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol 31: 139-143, 2011
80. De Deyn PP, Vanholder R, Eloot S, Glorieux G: Guanidino compounds as uremic (neuro) toxins. Semin Dial 22: 340-345, 2009
81. D'Hooge R, Pei YQ, Marescau B, De Deyn PP: Convulsive action and toxicity of uremic guanidino compounds: Behavioral assessment and relation to brain concentration in adult mice. J Neurol Sci 112: 96-105, 1992
82. Perna AF, Ingrosso D, Satta E, Lombardi C, Galletti P, D'Aniello A, De Santo NG: Plasma protein aspartyl damage is increased in hemodialysis patients: Studies on causes and consequences. J Am Soc Nephrol 15: 2747-2754, 2004 (Pubitemid 41103382)
83. Yaffe K, Lindquist K, Shlipak MG, Simonsick E, Fried L, Rosano C, Satterfield S, Atkinson H, Windham BG, Kurella-TamuraM: Cystatin C as a marker of cognitive function in elders: Findings from the health ABC study. Ann Neurol 63: 798-802, 2008 (Pubitemid 351945540)
84. Kurella M, Yaffe K, Shlipak MG, Wenger NK, Chertow GM: Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis 45: 66-76, 2005 (Pubitemid 40038046)
85. Seliger SL, LongstrethWT Jr., Katz R,Manolio T, Fried LF, Shlipak M, Stehman-Breen CO, Newman A, Sarnak M, Gillen DL, Bleyer A, Siscovick DS: Cystatin C and subclinical brain infarction.JAmSocNephrol 16: 3721-3727, 2005 (Pubitemid 46211294)
86. Kobayashi M, Hirawa N, Yatsu K, Kobayashi Y, Yamamoto Y, Saka S, Andoh D, Toya Y, Yasuda G, Umemura S: Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant 24: 201-207, 2009